Intra-uterine growth restriction downregulates the hepatic toll like receptor-4 expression and function

Clinical and Developmental Immunology

Volumn 12, Issue 1, 2005, Pages 59-66

  Equils, Ozlem ^a,c   Singh, Sapna ^b   Karaburun, Semra ^a   Lu, Daning ^a   Thamotharan, Manikkavasagar ^a   Devaskar, Sherin U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Intrauterine growth retardation; Neonate; Sepsis; Starvation; Toll like receptor

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CELL SURFACE RECEPTOR; INTERLEUKIN 1; MEMBRANE PROTEIN; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOOD INTAKE; GRAM NEGATIVE SEPSIS; INFECTION RISK; INFLAMMATORY DISEASE; INTESTINE; INTRAUTERINE GROWTH RETARDATION; LIVER; MILK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RAT; SPLEEN; STARVATION; SUCKLING; AGING; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UTERUS;

AGING; ANIMALS; ANIMALS, NEWBORN; DOWN-REGULATION; FEMALE; FETAL GROWTH RETARDATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LIVER; MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 18444416833     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1080/17402520400008905     Document Type: Article

References (54)

1. Alves-Rosa F, Vulcano M, Beigie-Bompadre M, Fernandez G, Palermo M, Isturiz MA. 2002. Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice. Clin Exp Immunol 128:221-228.
2. Barton GM, Medzhitov R. 2002. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 14:380-383.
3. Beach RS, Gershwin ME, Hurley LS. 1982. Gestational zinc deprivation in mice: Persistence of immunodeficiency for three generations. Science 218:469-471.
4. Beutler B. 2002. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 270:109-120.
5. Beutler B, Du X, Poltorak A. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: Genetic and evolutionary studies. J Endotoxin Res 7:277-280.
6. Biragyn A, Ruffini PA, Leifer CA, et al. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029.
7. Bulut Y, Faure E, Thomas L, et al. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168:1435-1440.
8. Chandra RK. 1975a. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. Br Med J 2:583-585.
9. Chandra RK. 1975b. Fetal malnutrition and postnatal immunocompetence. Am J Dis Child 129:450-454.
10. Chandra RK. 1975c. Antibody formation in first and second-generation offspring of nutritionally deprived rats. Science 190:289-290.
11. Chandra RK. 1981. Serum thymic hormone activity and cell-mediated immunity in healthy neonates, preterm infants, and small-for-gestational age infants. Pediatrics 67:407-411.
12. Chandra RK. 2002. Nutrition and the immune system from birth to old age. Eur J Clin Nutr 56(Suppl 3):S73-S76.
13. Duesberg U, von dem Bussche A, Kirschning C, Miyake K, Sauerbruch T, Spengler U. 2002. Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)-core protein is mediated by Toll like receptors (TLRs) 2 and 4. Immunol Lett 84:89.
14. Ferguson AC. 1978. Prolonged impairment of cellular immunity in children with intrauterine growth retardation. J Pediatr 93:52-56.
15. Fernandez-Real JM, Vayreda M, Richart C, et al. 2001. Circulating interleukin-6 levels, blood pressure and insulin resistance in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159.
16. Godfrey KM, Barker DJP, Osmond C. 1994. Disproportionate fetal growth and raised IgE concentration in adult life. Clin Exp Allergy 24:641-648.
17. Harju K, Glumoff V, Hallman M. 2001. Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr Res 49:81-83.
18. Hasselbalch H, Ersboll AK, Jeppesen DL, Nielsen MB. 1999. Thymus size in infants from birth until 24 months of age evaluated by ultrasound. A longitudinal prediction model for the thymic index. Acta Radiol 40:41-44.
19. Holemans K, Van Bree R, Verhaeghe J, Meurrens K, Van Assche FA. 1997. Maternal semistarvation and streptozotocin-diabetes in rats have different effects on the in vivo glucose uptake by peripheral tissues in their female adult offspring. J Nutr 127:1371-1376.
20. Hoshino K, Takeuchi O, Kawai T, et al. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:374.
21. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Investig 95:2409-2415.
22. Jiang ZH, Koganty RR. 2003. Synthetic vaccines: The role of adjuvants in immune targeting. Curr Med Chem 10:1423-1439.
23. Katsuki A, Sumida Y, Murashima S, et al. 1998. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862.
24. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. 2000. Mouse Toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275:2251-2254.
25. Kurose I, Miura S, Higuchi H, et al. 1996. Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factor alpha. Hepatology 24:1185-1192.
26. Kurt-Jones EA, Popova L, Kwinn L, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401.
27. Liu S, Khemlani LS, Shapiro RA, Johnson ML, et al. 1998. Expression of CD14 by hepatocytes: Upregulation by cytokines during endotoxemia. Infect Immun 66:5089-5098.
28. Liu S, Gallo DJ, Green AM, et al. 2002. Role of Toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70:3433-3442.
29. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. 2000. Endotoxin and cytokine regulation of Toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interf Cytok Res 20:915-921.
30. McMillan DE. 1989. Increased levels of acute-phase serum proteins in diabetes. Metabolism 38:1042-1046.
31. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. 2001. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with type 2 diabetes mellitus. Diabet Res Clin Pract 52:119-123.
32. Mitka M. 2002. Not enough food (instead of too much) is also a problem in the United States. JAMA 288:1462-1463.
33. Miyake K, Ogata H, Nagai Y, Akashi S, Kimoto M. 2000. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J Endotoxin Res 6:389-391.
34. Modlin RL. 2002a. Mammalian toll-like receptors. Ann Allergy Asthma Immunol 88:543-547.
35. Modlin RL. 2002b. Mammalian toll-like receptors. Ann Allergy Asthma Immunol 8:543-547.
36. Moore SE. 1998. Nutrition, immunity and the fetal and infant origins of disease hypothesis in developing countries. Proc Nutr Soc 57:241-247.
37. Moscatelli P, Bricarelli FD, Piccinini A, Tomatis C, Dufour MA. 1976. Defective immunocompetence in foetal undernutrition. Helv Paediatr Acta 31:241-247.
38. Muzio M, Bosisio D, Polentarutti N, et al. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes. J Immunol 164:5998-6004.
39. Ohashi K, Burkart V, Flohe S, Kolb H. 2000. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558-561.
40. Okamura Y, Watari M, Jerud ES, et al. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276:10229-10233.
41. Phillips DIW, Cooper C, Fall C, et al. 1993. Fetal growth and autoimmune thyroid disease. Q J Med 86:247-253.
42. Pickup JC, Crook MA. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241-1248.
43. Pickup JC, Mattock MB, Chusney GD, Burt D. 1997. NIDDM as a disease of the innate immune system: Association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292.
44. Poltorak A, He X, Smirnova I, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085.
45. Ravelli AC, van der Meulen JH, Michels RP, et al. 1998. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351:173-177.
46. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. 2002. Cutting edge: Impaired toll-like receptor expression and function in aging. J Immunol 169:4697-4701.
47. Rietschel ET, Brade H, Holst O, et al. 1996. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216:40-81.
48. Sagizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. 1996. The expression of TNF-alpha by human muscle: Relationship to insulin resistance. J Clin Investig 97:1111-1116.
49. Simchen MJ, Beiner ME, Strauss-Liviathan N, et al. 2000. Neonatal outcome in growth-restricted versus appropriately grown preterm infants. Am J Perinatol 17:187-192.
50. Tanikawa K, Mimura Y, Sakisaka S, Noguchi K. 1998. Role of hepatocytes in the clearance of lipopolysaccharide and its clinical significance. Prog Clin Biol Res 397:191-198.
51. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614.
52. Vodovotz Y, Liu S, McCloskey C, Shapiro R, Green A, Billiar TR. 2001. The hepatocyte as a microbial product-responsive cell. J Endotoxin Res 7:365-7357.
53. Wenzel RP, Pinsky MR, Ulevitch RJ, Young L. 1996. Current understanding of sepsis. Clin Infect Dis 22:407-413.
54. Zarember KA, Godowski PJ. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168:554-561.